Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Barberis

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Current Oncology (Toronto, Ont.)|September 30, 2021
Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature ReviewCarmine Valenza, Francesca Maria Porta, Alessandra Rappa, et al.
Pharmacological Research|January 17, 2017
Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatmentAntonio Passaro, Elena Guerini-Rocco, Alessia Pochesci, et al.
Clinical Lung Cancer|June 29, 2016
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung CancerChiara Catania, Antonio Passaro, Elena Guerini Rocco, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter StudyElena Guerini Rocco, Albino Eccher, Ilaria Girolami, et al.
Journal of Cellular Physiology|December 7, 2005
SEL1L a multifaceted protein playing a role in tumor progressionIda Biunno, Monica Cattaneo, Rosaria Orlandi, et al.
Oncotargets and Therapy|August 29, 2015
Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)Gianluca Spitaleri, Roberto Biffi, Massimo Barberis, et al.
Neurology|December 21, 2012
Complete stable remission and autoantibody specificity in myasthenia gravisFulvio Baggi, Francesca Andreetta, Lorenzo Maggi, et al.
Critical Reviews in Oncology/Hematology|October 26, 2013
Targeting ALK in patients with advanced non small cell lung cancer: biology, diagnostic and therapeutic optionsChiara Lazzari, Gianluca Spitaleri, Chiara Catania, et al.
Journal of Clinical Pathology|July 27, 2021
Microsatellite instability evaluation: which test to use for endometrial cancer?Paola Rafaniello-Raviele, Ilaria Betella, Alessandra Rappa, et al.
Pathologica|February 15, 2023
Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology UnitsCarlo Lazzaro, Giovanni Fattore, Massimo Barberis, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Current Oncology (Toronto, Ont.)|September 30, 2021
Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature ReviewCarmine Valenza, Francesca Maria Porta, Alessandra Rappa, et al.
Pharmacological Research|January 17, 2017
Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatmentAntonio Passaro, Elena Guerini-Rocco, Alessia Pochesci, et al.
Clinical Lung Cancer|June 29, 2016
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung CancerChiara Catania, Antonio Passaro, Elena Guerini Rocco, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter StudyElena Guerini Rocco, Albino Eccher, Ilaria Girolami, et al.
Journal of Cellular Physiology|December 7, 2005
SEL1L a multifaceted protein playing a role in tumor progressionIda Biunno, Monica Cattaneo, Rosaria Orlandi, et al.
Oncotargets and Therapy|August 29, 2015
Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)Gianluca Spitaleri, Roberto Biffi, Massimo Barberis, et al.
Neurology|December 21, 2012
Complete stable remission and autoantibody specificity in myasthenia gravisFulvio Baggi, Francesca Andreetta, Lorenzo Maggi, et al.
Critical Reviews in Oncology/Hematology|October 26, 2013
Targeting ALK in patients with advanced non small cell lung cancer: biology, diagnostic and therapeutic optionsChiara Lazzari, Gianluca Spitaleri, Chiara Catania, et al.
Journal of Clinical Pathology|July 27, 2021
Microsatellite instability evaluation: which test to use for endometrial cancer?Paola Rafaniello-Raviele, Ilaria Betella, Alessandra Rappa, et al.
Pathologica|February 15, 2023
Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology UnitsCarlo Lazzaro, Giovanni Fattore, Massimo Barberis, et al.
Pageof 17